Group 1 - Libet has received approval from the China Securities Regulatory Commission for the issuance of convertible bonds, valid for 12 months [1] - Dinglong plans to acquire an additional 8% stake in its subsidiary, increasing its ownership from 91.35% to 99.35% for a total price of 240 million yuan [1] - Longyuan Donggu has been designated as a supplier for a major automotive project, with an expected total sales amount of 450 to 500 million yuan over five years [14] Group 2 - Luoniushan reported a sales revenue of 100 million yuan in May, a year-on-year decrease of 11.45% [2] - Baoming Technology has secured a loan commitment of up to 7 million yuan for stock repurchase [2] - Xinhua Pharmaceutical has received approval for the listing of a new chemical raw material used in treating chronic heart failure and hypertension [3] Group 3 - China Minmetals announced a new contract amount of 396 billion yuan for the first five months of the year, a decrease of 22.2% year-on-year [7] - Zhongbei Communication's application for a specific stock issuance has been accepted by the Shanghai Stock Exchange [8] - Rongfa Nuclear Power plans to issue bonds not exceeding 1 billion yuan to repay debts and supplement working capital [9] Group 4 - Phoenix Optical plans to invest 8.5 million USD to establish a wholly-owned subsidiary in Vietnam for manufacturing optical products [11] - Xiamen Airport reported a passenger throughput of 2.4752 million in May, a year-on-year increase of 8.34% [12] - Weilan Biological has received a new veterinary drug registration certificate for a product aimed at treating canine allergies and inflammation [13] Group 5 - Shouxiangu has completed the registration of a health food product that claims to enhance immunity [13] - Xingye Yinxin's subsidiary has passed a resource reserve verification report, confirming significant mineral reserves [16] - Shaanxi Construction has won two major projects with a total contract value exceeding 2.8 billion yuan [18] Group 6 - Huari received a cash dividend of 50 million yuan from its subsidiary [20] - Zhongchu's deputy general manager has resigned due to governance arrangements [21] - Kexin Pharmaceutical's core product has received breakthrough therapy designation from the National Medical Products Administration [39]

证券代码： 600061 证券简称：国投资本 公告编号：2025-033 国投资本股份有限公司 关于董事长离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 国投资本股份有限公司（以下简称"公司"）于近日收到公 司董事长段文务先生提交的书面辞职报告。段文务先生因工作调 动原因辞去公司董事长、董事职务，同时辞去董事会战略与 ESG 委员会主任委员、提名委员会委员职务。 二、离任对公司的影响 根据《中华人民共和国公司法》《国投资本股份有限公司章 程》等有关规定，段文务先生的辞职不会导致公司董事会成员低 于法定最低人数，不会影响公司董事会正常运作，其辞职报告自 1 姓名 离任职务 离任时间 原定任期 到期日 离任原因 是否继续在 上市公司及 其控股子公 司任职 是否存在 未履行完 毕的公开 承诺 段文务 董事长、董事、 董事会战略与 ESG 委员会主 任委员、提名 委员会委员 2025-6-10 2026-4-18 工作调动 是 否 一、离任的基本情况 送达董事会之日起生效。段文务先生已按照公司相关规定做好工 作交接。鉴于新 ...

Group 1 - Duan Wenwu has officially resigned as the chairman of Guotou Capital, effective June 10, after two years and two months in the role, and has taken a new position as Chief Accountant at China Minmetals Corporation [1][3] - Guotou Capital expressed gratitude for Duan Wenwu's contributions during his tenure, highlighting his efforts in building an industrial financial management platform and enhancing the company's core competitiveness [3] - Duan Wenwu's departure may also lead to his resignation from the chairman position at Guotou Securities, a subsidiary of Guotou Capital [1][3] Group 2 - Under Duan Wenwu's leadership, Guotou Capital completed the rebranding of Anxin Securities to Guotou Securities, aligning the name with its parent company [5] - The name change was part of a strategic optimization plan by Guotou Group, which identified the securities business as a key component of its industrial finance strategy [6] - The rebranding aims to enhance the company's role as a professional intermediary in the capital market and is expected to receive support from Guotou Group in various aspects, including resource allocation and regional collaboration [6]

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets have announced significant developments, including asset restructuring, acquisitions, and financial performance updates, which may present investment opportunities and risks for investors [2]. Major Events - Zhongke Shuguang will hold an investor briefing on June 11 regarding a major asset restructuring with Haiguang Information Technology [3]. - Redik plans to acquire 51% of Chengzhan Precision Technology for a total consideration of 104 million yuan, aiming to enter the embodied intelligence sector [4]. - *ST King Kong signed a restructuring investment agreement with Ouhao Group, with a share price of 4.96 yuan per share, raising between 268 million yuan and 402 million yuan [5]. - *ST Bosen clarified that its upcoming shareholder meeting is unrelated to any plans for a reverse merger with Xifeng Liquor [6]. - Guotou Capital announced the resignation of its chairman due to work relocation [7]. - Vanke A sold 22 million A-shares for 146 million yuan to enhance liquidity without impacting current profits [8]. Financial Performance - Tiankang Biological reported May sales of 22.97 million pigs, with revenue of 345 million yuan, reflecting a year-on-year decline of 19.95% [18]. Shareholding Changes - Qu Mei Home's director reduced holdings by 58,000 shares during a period of significant stock price volatility [19]. Financing Activities - Founder Technology plans to raise up to 1.98 billion yuan through a private placement to fund an AI and high-density interconnect circuit board project [20]. Major Contracts - Tengda Construction won a bid for the Fanglin Automotive Cloud Warehouse project, valued at 349 million yuan, representing 9.38% of its projected 2024 revenue [21].

证券代码： 600061 证券简称：国投资本 公告编号：2025-033 国投资本股份有限公司 关于董事长离任的公告 动原因辞去公司董事长、董事职务，同时辞去董事会战略与 ESG 委员会主任委员、提名委员会委员职务。 一、离任的基本情况 | | | | 是否继续在 | 是否存在 | | --- | --- | --- | --- | --- | | | | 原定任期 | 上市公司及 | 未履行完 | | 姓名 | 离任职务 | 离任时间 | 离任原因 | | | | | 到期日 | 其控股子公 | 毕的公开 | | | | | 司任职 | 承诺 | 董事长、董事、 董事会战略与 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 国投资本股份有限公司（以下简称"公司"）于近日收到公 司董事长段文务先生提交的书面辞职报告。段文务先生因工作调 段文务 ESG 委员会主 2025-6-10 2026-4-18 工作调动 是 否 任委员、提名 委员会委员 二、离任对公司的影响 根据《中华人民共和国公司法》《国投资本股份有限公司章 程》等有 ...

证券代码： 600061 证券简称：国投资本 公告编号：2025-033 国投资本股份有限公司 根据《中华人民共和国公司法》《国投资本股份有限公司章 程》等有关规定，段文务先生的辞职不会导致公司董事会成员低 于法定最低人数，不会影响公司董事会正常运作，其辞职报告自 1 姓名 离任职务 离任时间 原定任期 到期日 离任原因 是否继续在 上市公司及 其控股子公 司任职 是否存在 未履行完 毕的公开 承诺 段文务 董事长、董事、 董事会战略与 ESG 委员会主 任委员、提名 委员会委员 2025-6-10 2026-4-18 工作调动 是 否 一、离任的基本情况 送达董事会之日起生效。段文务先生已按照公司相关规定做好工 作交接。鉴于新任董事长的选举工作尚需经过相应的法定程序， 公司将按照法定程序尽快完成公司董事长的补选等相关工作。 关于董事长离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 国投资本股份有限公司（以下简称"公司"）于近日收到公 司董事长段文务先生提交的书面辞职报告。段文务先生因工作调 动原因辞去公司董事长、 ...

国投资本（600061）公告，公司董事长段文务因工作调动于2025年6月10日提交书面辞职报告，辞去董 事长、董事职务以及董事会战略与ESG委员会主任委员、提名委员会委员职务。段文务自2023年4月18 日起担任董事长，任期原定至2026年4月18日。公司将尽快完成新任董事长的补选等相关工作。 ...

【导读】李樱履新，任中国华能集团总会计师、党组成员 见习记者舍梨 近日，中国华能集团有限公司网站"公司领导"一栏最新信息显示，李樱已任中国华能集团总会计师、党组成员。 李樱出任中国华能总会计师 公开资料显示，李樱，女，1974年生，经济学硕士，现任中国华能集团有限公司总会计师、党组成员。她曾长期在国投系企业任职，担任过国投电力控股 股份有限公司证券部经理兼证券事务代表，国投财务有限公司总经理助理、副总经理，国投资本控股有限公司副总经理、董事会秘书兼财务总监等职务， 2018年任国投资本总经理，2023年任国投泰康信托有限公司董事长，直至此次履新中国华能集团。 中国华能集团和国投集团均为中央企业，在国务院国资委2024年10月发布的98家央企名录中，中国华能和国投集团分别位列第17位、第49位。 中国华能集团创立于1985年。公司注册资本为349亿元人民币，主营业务包括电源开发、投资、建设、经营和管理，电力（热力）生产和销售，金融、煤 炭、交通运输、新能源、环保相关产业及产品的开发、投资、建设、生产、销售，实业投资经营及管理。目前，中国华能集团拥有57家二级单位、480余 家三级企业，5家上市公司（分别为华能国 ...

截至2025年6月6日收盘，国投资本（600061）报收于7.12元，较上周的6.97元上涨2.15%。本周，国投 资本6月6日盘中最高价报7.2元。6月3日盘中最低价报6.94元。国投资本当前最新总市值455.25亿元，在 多元金融板块市值排名2/28，在两市A股市值排名295/5148。 本周关注点 公司公告汇总：截至2025年5月30日收盘，国投资本尚未实施股份回购，累计已回购股数0股 公司公告汇总 国投资本股份有限公司关于以集中竞价交易方式回购公司股份的进展公告指出，回购方案首次披露日为 2025年4月10日，实施期限从2025年4月9日至2026年4月8日，预计回购金额介于20000万元到40000万元 之间，回购用途为用于转换公司可转债。截至2025年5月30日收盘，公司尚未实施股份回购，累计已回 购股数为0股，占总股本比例0%，累计已回购金额为0元，实际回购价格区间为0元每股到0元每股。 2025年4月9日，国投资本召开九届二十二次董事会审议通过了以集中竞价交易方式回购公司A股股份的 议案，回购资金总额不低于人民币2亿元且不超过人民币4亿元，回购价格不超过人民币8.90元每股，回 购股份实施期限 ...

Core Viewpoint - The article discusses the recent trend of share buybacks among A-share listed companies, particularly focusing on the rapid progress made by several securities firms in implementing their buyback plans amidst market fluctuations and regulatory support [1][2][3]. Group 1: Buyback Trends - In April 2025, over 240 companies announced share buyback plans, a significant increase from 44 in March, with a total proposed buyback amount of approximately 735.25 billion yuan, up 257.14% from the previous month [2]. - Notable securities firms such as Guotai Junan, Guojin Securities, and Dongfang Securities have reported swift progress in their buyback initiatives, with some already meeting the minimum requirements of their plans [3][4]. Group 2: Specific Buyback Progress - Guotai Junan Securities approved a buyback plan with a budget between 1 billion and 2 billion yuan, and as of May 31, 2025, it had repurchased 32.488 million shares, accounting for 0.18% of its total share capital, with a total expenditure of 557 million yuan [3]. - Dongfang Securities initiated a buyback plan of 250 million to 500 million yuan and reported having repurchased 240 million yuan worth of shares within a month, nearing its minimum target [3]. - Guojin Securities announced a buyback plan of 50 million to 100 million yuan and had repurchased 675,110 shares for a total of 55.73 million yuan by May 31, 2025 [3]. Group 3: Slow Progress by Some Firms - Some firms, such as Guotou Securities and Zhongtai Securities, have not yet initiated their buyback plans, despite having approved them earlier. Guotou Securities had a buyback budget of 200 million to 400 million yuan, while Zhongtai Securities planned to use 300 million to 500 million yuan for its buyback [4][5]. - Both firms still have time to implement their buyback actions, with deadlines extending into the latter half of 2025 [6]. Group 4: Market Implications - The article highlights that under supportive policies, the scale of buybacks and share repurchases by listed companies is expected to continue increasing, which could enhance investor sentiment and stabilize market expectations [6]. - Regulatory bodies have emphasized the importance of genuine buyback actions to avoid misleading practices that could disrupt market expectations and harm investor interests [6].